Balance Sheet Nanologica AB

Equities

NICA

SE0005454873

Commodity Chemicals

Market Closed - Nasdaq Stockholm Other stock markets 12:00:00 2025-07-09 pm EDT			5-day change	1st Jan Change
1.170 ^SEK	+7.34%		+6.36%	-35.71%

Jun. 13	Nanologica Board Recommends Not To Accept Cash Offer Made By Flerie Invest	RE
Jun. 13	Nanologica's board of directors advises against accepting Flerie's mandatory bid offer.	FW

f28f0.BFL_SWO_2tmWYAjnSyGnvdc3Br4IKd0N3j_i9ksxvP0.YjmXPzfKq77zJGPeAHH22_p_NfU-Xr88mG2rlS1_9olQHaBkU9vrqdELRQ

Published financial data: NANOLOGICA AB

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	18.22M	14.72M	5.83M	4.67M	14.54M
Other Revenues, Total	112K	23K	7K	-	-
Total Revenues	18.34M	14.75M	5.83M	4.67M	14.54M
Cost of Goods Sold, Total	3.23M	9.8M	2.59M	4.75M	10.24M
Gross Profit	15.1M	4.94M	3.24M	-76K	4.29M
Selling General & Admin Expenses, Total	29.55M	33.8M	41.52M	40.5M	38.68M
Depreciation & Amortization - (IS)	5.67M	4.09M	11.86M	19.36M	15.55M
Other Operating Expenses	-10K	-295K	-	-192K	8.41M
Other Operating Expenses, Total	35.21M	37.6M	53.38M	59.68M	62.64M
Operating Income	-20.1M	-32.66M	-50.14M	-59.75M	-58.35M
Interest Expense, Total	-3.48M	-3.23M	-5.01M	-5.71M	-6.3M
Interest And Investment Income	-	-	42K	464K	354K
Net Interest Expenses	-3.48M	-3.23M	-4.97M	-5.25M	-5.95M
Income (Loss) On Equity Invest.	-	-	-	-	-
Currency Exchange Gains (Loss)	532K	-497K	-269K	-114K	-1.3M
Other Non Operating Income (Expenses)	1K	1K	1K	-	-
EBT, Excl. Unusual Items	-23.05M	-36.39M	-55.37M	-65.12M	-65.59M
Gain (Loss) On Sale Of Investments	851K	-902K	630K	-	-
Gain (Loss) On Sale Of Assets	-	-1.17M	-489K	-257K	-
Asset Writedown	-	-6.37M	-	-9.78M	-
EBT, Incl. Unusual Items	-22.2M	-44.83M	-55.23M	-75.16M	-65.59M
Income Tax Expense	-	-	-	-	35K
Earnings From Continuing Operations	-22.2M	-44.83M	-55.23M	-75.16M	-65.63M
Net Income to Company	-22.2M	-44.83M	-55.23M	-75.16M	-65.63M
Net Income - (IS)	-22.2M	-44.83M	-55.23M	-75.16M	-65.63M
Net Income to Common Incl Extra Items	-22.2M	-44.83M	-55.23M	-75.16M	-65.63M
Net Income to Common Excl. Extra Items	-22.2M	-44.83M	-55.23M	-75.16M	-65.63M
Per Share Items
Net EPS - Basic	-0.93	-1.6	-1.84	-2.08	-1.32
Basic EPS - Continuing Operations	-0.93	-1.6	-1.84	-2.08	-1.32
Basic Weighted Average Shares Outstanding	23.89M	28M	30.02M	36.15M	49.53M
Net EPS - Diluted	-0.93	-1.6	-1.84	-2.08	-1.32
Diluted EPS - Continuing Operations	-0.93	-1.6	-1.84	-2.08	-1.32
Diluted Weighted Average Shares Outstanding	23.89M	28M	30.02M	36.15M	49.53M
Normalized Basic EPS	-0.6	-0.81	-1.15	-1.13	-0.83
Normalized Diluted EPS	-0.6	-0.81	-1.15	-1.13	-0.83
Supplemental Items
EBITDA	-19.19M	-31.46M	-48.95M	-58.9M	-57.24M
EBITA	-19.66M	-32.09M	-49.59M	-59.19M	-57.96M
EBIT	-20.1M	-32.66M	-50.14M	-59.75M	-58.35M
EBITDAR	-	-	-45.99M	-55.94M	-53.69M
Total Revenues (As Reported)	20.03M	13.51M	-	-	-
Effective Tax Rate - (Ratio)	-	-	-	-	-0.05
Normalized Net Income	-14.41M	-22.74M	-34.61M	-40.7M	-41M
Interest on Long-Term Debt	304K	273K	194K	82K	99K
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	3.26M	3.82M	4.14M	7.3M	6.58M
Net Rental Expense, Total	-	-	2.96M	2.96M	3.55M
Imputed Operating Lease Interest Expense	-	-	2.2M	1.95M	3.02M
Imputed Operating Lease Depreciation	-	-	766K	1.01M	526K

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	66.36M	10.99M	70.32M	10.05M	48.43M
Short Term Investments	-	-	-	-	-
Trading Asset Securities, Total	1.62M	714K	-	-	-
Total Cash And Short Term Investments	67.98M	11.7M	70.32M	10.05M	48.43M
Accounts Receivable, Total	6.81M	1.42M	770K	473K	896K
Other Receivables	2.16M	1.59M	2.77M	2.05M	889K
Total Receivables	8.97M	3.01M	3.54M	2.52M	1.78M
Inventory	4.59M	2.41M	1.17M	2.97M	32.74M
Prepaid Expenses	17.32M	39.69M	41.62M	22.98M	30.5M
Other Current Assets, Total	2.31M	-	-1K	-	1K
Total Current Assets	101M	56.8M	117M	38.53M	113M
Gross Property Plant And Equipment	33.84M	30.36M	25.16M	19.64M	18.82M
Accumulated Depreciation	-2.4M	-3.03M	-3.43M	-3.88M	-4.42M
Net Property Plant And Equipment	31.45M	27.33M	21.73M	15.76M	14.4M
Long-term Investments	-	-	-	-	-
Other Intangibles, Total	1.63M	1.88M	1.41M	1.33M	-
Deferred Charges Long-Term	12.11M	12.3M	14.72M	21.81M	15.23M
Other Long-Term Assets, Total	-1K	1K	1K	-	-
Total Assets	146M	98.32M	155M	77.43M	143M
Liabilities
Accounts Payable, Total	3.01M	3.68M	2.26M	4.91M	13.1M
Accrued Expenses, Total	3.99M	2.15M	3.09M	4.43M	2.75M
Short-term Borrowings	-	-	-	-	47.79M
Current Portion of Long-Term Debt	2.72M	2.36M	1.33M	-	-
Current Portion of Leases	2.12M	2.74M	2.69M	530K	2.9M
Unearned Revenue Current, Total	3.44M	946K	1.64M	-	-
Other Current Liabilities	2.46M	2.62M	2.49M	1.98M	2.16M
Total Current Liabilities	17.74M	14.5M	13.52M	11.86M	68.7M
Long-Term Debt	30.69M	28.33M	66.6M	66.76M	24K
Long-Term Leases	4.43M	3.36M	666K	136K	258K
Other Non Current Liabilities	517K	530K	574K	571K	-
Total Liabilities	53.38M	46.72M	81.36M	79.33M	68.99M
Common Stock, Total	11.4M	11.55M	14.82M	14.82M	8.84M
Additional Paid In Capital	231M	235M	308M	308M	442M
Retained Earnings	-150M	-195M	-250M	-325M	-377M
Comprehensive Income and Other	-	-	-	-	-1K
Total Common Equity	92.97M	51.6M	73.16M	-1.9M	74.11M
Total Equity	92.97M	51.6M	73.16M	-1.9M	74.11M
Total Liabilities And Equity	146M	98.32M	155M	77.43M	143M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	27.78M	28.17M	36.15M	36.15M	88.36M
ECS Total Common Shares Outstanding	27.78M	28.17M	36.15M	36.15M	88.36M
Book Value / Share	3.35	1.83	2.02	-0.05	0.84
Tangible Book Value	91.34M	49.72M	71.75M	-3.23M	74.11M
Tangible Book Value Per Share	3.29	1.77	1.99	-0.09	0.84
Total Debt	39.96M	36.79M	71.29M	67.42M	50.97M
Net Debt	-28.02M	25.09M	971K	57.37M	2.54M
Debt Equivalent Oper. Leases	-	-	23.7M	23.66M	28.37M
Account Code - Inventory Valuation	6	5	5	5	5
Inventories - Raw Materials, Total	-	53K	288K	131K	131K
Inventories - Work In Process, Total	-	2.19M	757K	2.73M	3.81M
Inventories - Finished Goods, Total	-	167K	125K	114K	28.81M
Machinery, Total	4.42M	5.28M	6.62M	7.63M	7.61M
Full Time Employees	20	17	20	16	16
Accumulated Allowance for Doubtful Accounts (Supple)	-	122K	140K	136K	148K

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	-22.2M	-44.83M	-55.23M	-75.16M	-65.63M
Depreciation & Amortization - CF	4.76M	7M	7.17M	6.62M	7.16M
Amortization of Goodwill and Intangible Assets - (CF)	448K	573K	549K	560K	386K
Depreciation & Amortization, Total	5.21M	7.57M	7.72M	7.18M	7.54M
Amortization of Deferred Charges, Total - (CF)	3.26M	3.82M	4.14M	7.3M	6.58M
Asset Writedown & Restructuring Costs	-	1.17M	498K	4.74M	1.43M
Other Operating Activities, Total	-1.88M	-2.36M	-1.64M	10.98M	8.68M
Change In Accounts Receivable	-25.95M	-12.24M	-1.83M	8.67M	-12.38M
Change In Inventories	-797K	2.18M	1.24M	-1.8M	-29.77M
Change In Accounts Payable	-	-	-	-	-
Change in Other Net Operating Assets	-989K	-1.81M	-117K	2.24M	2.81M
Cash from Operations	-43.34M	-46.49M	-45.22M	-35.85M	-80.73M
Capital Expenditure	-1.5M	-808K	-1.6M	-1.76M	-262K
Sale of Property, Plant, and Equipment	-	-	72K	627K	-
Cash Acquisitions	-	-	-	-	-
Divestitures	-	-	-	-	-
Sale (Purchase) of Intangible assets	-1.93M	-5.12M	-6.96M	-19.22M	-480K
Investment in Marketable and Equity Securities, Total	-	-	1.34M	-	-
Other Investing Activities, Total	-3.1M	-1.32M	-	-	-
Cash from Investing	-6.52M	-7.25M	-7.14M	-20.35M	-742K
Long-Term Debt Issued, Total	10M	-	50M	-	15M
Total Debt Issued	10M	-	50M	-	15M
Long-Term Debt Repaid, Total	-4.7M	-5.07M	-15.1M	-4.19M	-14.24M
Total Debt Repaid	-4.7M	-5.07M	-15.1M	-4.19M	-14.24M
Issuance of Common Stock	113M	3.45M	79.8M	-	131M
Other Financing Activities, Total	-3.59M	-20K	-3.01M	100K	-12.03M
Cash from Financing	115M	-1.64M	112M	-4.09M	120M
Foreign Exchange Rate Adjustments	-	4K	-1K	18K	-376K
Miscellaneous Cash Flow Adjustments	-	-	-	-	-
Net Change in Cash	65.19M	-55.38M	59.34M	-60.27M	38.38M
Supplemental Items
Cash Interest Paid	1.7M	5.56M	6.06M	4.2M	6.28M
Cash Income Tax Paid (Refund)	-	-	-	-	-
Levered Free Cash Flow	-34.29M	-32.39M	-32.3M	-27.72M	-56.9M
Unlevered Free Cash Flow	-32.11M	-30.37M	-29.17M	-24.15M	-52.96M
Change In Net Working Capital	24.59M	15.42M	1.14M	-19.7M	29.87M
Net Debt Issued / Repaid	5.3M	-5.07M	34.9M	-4.19M	764K

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	-12.71	-16.69	-24.79	-32.2	-33.07
Return on Total Capital	-14.53	-18.45	-26.92	-35.57	-38.27
Return On Equity %	-45.13	-62.02	-88.54	-210.94	-181.76
Return on Common Equity	-45.13	-62.02	-88.54	-210.94	-181.76
Margin Analysis
Gross Profit Margin %	82.38	33.52	55.57	-1.63	29.53
SG&A Margin	161.15	229.25	711.64	866.95	266.08
EBITDA Margin %	-104.65	-213.31	-839.06	-1.26K	-393.71
EBITA Margin %	-107.2	-217.6	-849.98	-1.27K	-398.71
EBIT Margin %	-109.65	-221.48	-859.39	-1.28K	-401.36
Income From Continuing Operations Margin %	-121.07	-304.01	-946.71	-1.61K	-451.43
Net Income Margin %	-121.07	-304.01	-946.71	-1.61K	-451.43
Net Avail. For Common Margin %	-121.07	-304.01	-946.71	-1.61K	-451.43
Normalized Net Income Margin	-78.57	-154.24	-593.2	-871.08	-281.99
Levered Free Cash Flow Margin	-187	-219.63	-553.69	-593.25	-391.41
Unlevered Free Cash Flow Margin	-175.15	-205.92	-500.03	-516.84	-364.31
Asset Turnover
Asset Turnover	0.19	0.12	0.05	0.04	0.13
Fixed Assets Turnover	0.59	0.5	0.24	0.25	0.96
Receivables Turnover (Average Receivables)	4.6	3.58	5.32	7.52	21.24
Inventory Turnover (Average Inventory)	0.77	2.8	1.45	2.29	0.57
Short Term Liquidity
Current Ratio	5.7	3.92	8.63	3.25	1.65
Quick Ratio	4.34	1.01	5.47	1.06	0.73
Operating Cash Flow to Current Liabilities	-2.44	-3.21	-3.35	-3.02	-1.18
Days Sales Outstanding (Average Receivables)	79.54	102.05	68.62	48.55	17.23
Days Outstanding Inventory (Average Inventory)	474.69	130.26	251.92	159.25	638.01
Average Days Payable Outstanding	221.12	160.28	801.71	199.94	82.39
Cash Conversion Cycle (Average Days)	333.11	72.03	-481.16	7.86	572.85
Long Term Solvency
Total Debt/Equity	42.99	71.31	97.45	-3.55K	68.77
Total Debt / Total Capital	30.06	41.62	49.35	102.9	40.75
LT Debt/Equity	37.78	61.42	91.95	-3.52K	0.38
Long-Term Debt / Total Capital	26.43	35.86	46.57	102.09	0.23
Total Liabilities / Total Assets	36.47	47.52	52.65	102.45	48.21
EBIT / Interest Expense	-5.78	-10.1	-10.01	-10.46	-9.26
EBITDA / Interest Expense	-4.28	-7.76	-8.47	-9.2	-8.06
(EBITDA - Capex) / Interest Expense	-4.71	-8.01	-8.79	-9.51	-8.1
Total Debt / EBITDA	-2.68	-1.47	-1.68	-1.28	-1
Net Debt / EBITDA	1.88	-1	-0.02	-1.09	-0.05
Total Debt / (EBITDA - Capex)	-2.44	-1.42	-1.62	-1.24	-1
Net Debt / (EBITDA - Capex)	1.71	-0.97	-0.02	-1.06	-0.05
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	50.04	-19.58	-60.43	-19.92	211.17
Gross Profit, 1 Yr. Growth %	88.65	-67.28	-34.4	-102.34	-5.75K
EBITDA, 1 Yr. Growth %	-2.18	111.15	29.41	20.31	-16.66
EBITA, 1 Yr. Growth %	-1.85	108.83	28.94	19.37	-15.97
EBIT, 1 Yr. Growth %	-1.7	106.54	28.45	19.18	-16.09
Earnings From Cont. Operations, 1 Yr. Growth %	5.31	101.94	23.2	36.08	-12.68
Net Income, 1 Yr. Growth %	5.31	101.94	23.2	36.08	-12.68
Normalized Net Income, 1 Yr. Growth %	10.93	94	29.49	17.6	-12.42
Diluted EPS Before Extra, 1 Yr. Growth %	-26.74	72.32	14.88	13.03	-36.28
Accounts Receivable, 1 Yr. Growth %	514.25	-79.14	-45.81	-38.57	89.43
Inventory, 1 Yr. Growth %	21.02	-47.53	-51.41	154.1	1K
Net Property, Plant and Equip., 1 Yr. Growth %	3.74	-13.08	-20.51	-27.48	-8.62
Total Assets, 1 Yr. Growth %	184.73	-32.82	57.16	-49.89	84.81
Tangible Book Value, 1 Yr. Growth %	2.16K	-45.57	44.32	-104.5	-2.39K
Common Equity, 1 Yr. Growth %	1.62K	-44.5	41.79	-102.59	-4K
Cash From Operations, 1 Yr. Growth %	343.56	7.28	-2.74	-20.72	125.21
Capital Expenditures, 1 Yr. Growth %	301.88	-46.1	97.9	9.82	-85.08
Levered Free Cash Flow, 1 Yr. Growth %	147.94	0.48	-13.4	-14.2	68.19
Unlevered Free Cash Flow, 1 Yr. Growth %	144.59	1.02	-17.31	-17.23	75.02
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	68.7	9.85	-43.59	-43.71	57.86
Gross Profit, 2 Yr. CAGR %	211.45	-21.43	-53.67	-87.6	15.07
EBITDA, 2 Yr. CAGR %	-3.48	26.63	81.27	24.78	8.13
EBITA, 2 Yr. CAGR %	-3.36	26.57	79.65	24.06	8.12
EBIT, 2 Yr. CAGR %	-3.07	26.37	78.06	23.73	7.88
Earnings From Cont. Operations, 2 Yr. CAGR %	3.09	45.83	57.73	29.48	9.01
Net Income, 2 Yr. CAGR %	3.09	45.83	57.73	29.48	9.01
Normalized Net Income, 2 Yr. CAGR %	1.49	32.34	71.81	23.4	8.84
Diluted EPS Before Extra, 2 Yr. CAGR %	-28.11	12.36	40.7	13.95	-15.13
Accounts Receivable, 2 Yr. CAGR %	175.19	13.2	-66.38	-42.31	7.87
Inventory, 2 Yr. CAGR %	30.62	-20.31	-49.51	11.11	429.03
Net Property, Plant and Equip., 2 Yr. CAGR %	460.99	-5.04	-16.88	-24.07	-18.59
Total Assets, 2 Yr. CAGR %	106.47	38.31	2.75	-11.26	-3.76
Tangible Book Value, 2 Yr. CAGR %	101.38	250.84	-11.37	-74.51	1.63
Common Equity, 2 Yr. CAGR %	98.02	208.79	-11.29	-80.82	0.65
Cash From Operations, 2 Yr. CAGR %	92.42	118.13	2.14	-12.19	33.62
Capital Expenditures, 2 Yr. CAGR %	-	47.18	3.28	47.42	-59.52
Levered Free Cash Flow, 2 Yr. CAGR %	134.25	53.03	0.11	-13.8	32.72
Unlevered Free Cash Flow, 2 Yr. CAGR %	141.92	52.08	-1.49	-17.27	34.74
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	56.33	31.79	-21.85	-36.6	-0.47
Gross Profit, 3 Yr. CAGR %	28.21	46.97	-26.02	-82.86	-4.58
EBITDA, 3 Yr. CAGR %	1.02	15.16	35.64	58.12	14.81
EBITA, 3 Yr. CAGR %	1.03	15.09	35.28	56.76	14.65
EBIT, 3 Yr. CAGR %	1.26	15.13	34.84	55.76	14.34
Earnings From Cont. Operations, 3 Yr. CAGR %	3.37	28.99	37.86	50.16	13.55
Net Income, 3 Yr. CAGR %	3.37	28.99	37.86	50.16	13.55
Normalized Net Income, 3 Yr. CAGR %	4.68	17.59	38.64	51.41	15.33
Diluted EPS Before Extra, 3 Yr. CAGR %	-40.23	-3.79	13.19	30.79	-6.12
Accounts Receivable, 3 Yr. CAGR %	53.38	16.46	-11.45	-58.9	-14.25
Inventory, 3 Yr. CAGR %	-2.23	-3.62	-32.43	-13.47	138.69
Net Property, Plant and Equip., 3 Yr. CAGR %	173.14	201.31	-10.5	-20.57	-19.24
Total Assets, 3 Yr. CAGR %	78.08	42.01	44.33	-19.12	13.33
Tangible Book Value, 3 Yr. CAGR %	334.67	30.2	160.93	-67.18	14.23
Common Equity, 3 Yr. CAGR %	263.32	29.59	138.23	-72.67	12.83
Cash From Operations, 3 Yr. CAGR %	23.17	58.37	66.65	-6.13	20.2
Capital Expenditures, 3 Yr. CAGR %	115.48	-	62.45	5.42	-31.3
Levered Free Cash Flow, 3 Yr. CAGR %	24.92	73.06	32.68	-4.91	15.12
Unlevered Free Cash Flow, 3 Yr. CAGR %	23.56	76.88	30.49	-7.04	14.5
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	14.49	27.89	3.98	-6.22	3.53
Gross Profit, 5 Yr. CAGR %	13.29	6.93	-14.67	-45.34	-11.72
EBITDA, 5 Yr. CAGR %	7.4	8.53	21.34	23.38	23.88
EBITA, 5 Yr. CAGR %	7.47	8.64	21.07	22.97	23.68
EBIT, 5 Yr. CAGR %	7.53	8.72	20.96	22.8	23.33
Earnings From Cont. Operations, 5 Yr. CAGR %	9.21	14.82	22.41	29.18	25.5
Net Income, 5 Yr. CAGR %	9.21	14.82	22.41	29.18	25.5
Normalized Net Income, 5 Yr. CAGR %	10.23	10.74	22.47	23.81	25.85
Diluted EPS Before Extra, 5 Yr. CAGR %	-31.86	-23.67	-15.82	2.95	0.88
Accounts Receivable, 5 Yr. CAGR %	59.51	5.26	-16.42	-12.06	-4.18
Inventory, 5 Yr. CAGR %	-	15.77	-24.94	2.02	53.91
Net Property, Plant and Equip., 5 Yr. CAGR %	83.56	71.45	69.72	73.61	-13.83
Total Assets, 5 Yr. CAGR %	34.89	25.27	42.92	17.66	22.73
Tangible Book Value, 5 Yr. CAGR %	31.31	18.62	130.11	-32.19	78.95
Common Equity, 5 Yr. CAGR %	30.95	18.55	106.71	-39.65	68.78
Cash From Operations, 5 Yr. CAGR %	25.45	14.93	14.29	25.09	52.55
Capital Expenditures, 5 Yr. CAGR %	18.91	-3.52	60.56	-	-6.82
Levered Free Cash Flow, 5 Yr. CAGR %	18.47	14.9	12.93	34.71	32.7
Unlevered Free Cash Flow, 5 Yr. CAGR %	17.05	13.6	11.37	34.49	32.17